Abstract
Varicella can cause complications that are potentially serious and require hospitalization. Our current understanding of the causes and incidence of varicella-related hospitalization in Turkey is limited and sufficiently accurate epidemiological and economical information is lacking. The aim of this study was to estimate the annual incidence of varicella-related hospitalizations, describe the complications, and estimate the annual mortality and cost of varicella in children. VARICOMP is a multi-center study that was performed to provide epidemiological and economic data on hospitalization for varicella in children between 0 and 15 years of age from October 2008 to September 2010 in Turkey. According to medical records from 27 health care centers in 14 cities (representing 49.3% of the childhood population in Turkey), 824 children (73% previously healthy) were hospitalized for varicella over the 2-year period. Most cases occurred in the spring and early summer months. Most cases were in children under 5 years of age, and 29.5% were in children under 1 year of age. The estimated incidence of varicella-related hospitalization was 5.29–6.89 per 100,000 in all children between 0–15 years of age in Turkey, 21.7 to 28 per 100,000 children under 1 year of age, 9.8–13.8 per 100,000 children under 5 years of age, 3.96–6.52 per 100,000 children between 5 and 10 years of age and 0.42 to 0.71 per 100,000 children between 10 and 15 years of age. Among the 824 children, 212 (25.7%) were hospitalized because of primary varicella infection. The most common complications in children were secondary bacterial infection (23%), neurological (19.1%), and respiratory (17.5%) complications. Secondary bacterial infections (p < 0.001) and neurological complications (p < 0.001) were significantly more common in previously healthy children, whereas hematological complications (p < 0.001) were more commonly observed in children with underlying conditions. The median length of the hospital stay was 6 days, and it was longer in children with underlying conditions (<0.001). The median cost of hospitalization per patient was $338 and was significantly higher in children with underlying conditions (p < 0.001). The estimated direct annual cost (not including the loss of parental work time and school absence) of varicella-related hospitalization in children under the age of 15 years in Turkey was $856,190 to $1,407,006. According to our estimates, 882 to 1,450 children are hospitalized for varicella each year, reflecting a population-wide occurrence of 466–768 varicella cases per 100,000 children. In conclusion, this study confirms that varicella-related hospitalizations are not uncommon in children, and two thirds of these children are otherwise healthy. The annual cost of hospitalization for varicella reflects only a small part of the overall cost of this disease, as only a very few cases require hospital admission. The incidence of this disease was higher in children <1 year of age, and there are no prevention strategies for these children other than population-wide vaccination. Universal vaccination is therefore the only realistic option for the prevention of severe complications and deaths. The surveillance of varicella-associated complications is essential for monitoring of the impact of varicella immunization.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Almuneef M, Memish ZA, Balkhy HH, Alotaibi B, Helmy M (2006) Chickenpox complications in Saudi Arabia: is it time for routine varicella vaccination? Int J Infect Dis 10:156–61
Alp H, Altinkaynak S, Ertekin V, Kiliçaslan B, Giiraksin A (2005) Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey. Health Policy 72:119–124
Azzari C, Massai C, Poggiolesi C, Indolfi G, Spagnolo G, De Luca M et al (2007) Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses. Curr Med Res Opin 23:2945–2954
Bonanni P, Breuer J, Gershon A, Gershon M, Hryniewicz W, Papaevangelou V et al (2009) Varicella vaccination in Europe—taking the practical approach. BMC Med 7:26
Bonhoeffer J, Baer G, Muehleisen B, Aebi C, Nadal D, Schaad UB et al (2005) Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr 164:366–370
Bonsignori F, Chiappini E, Frenos S, Peraldo M, Galli L, de Martino M (2007) Hospitalization rates for complicated and uncomplicated chickenpox in a poorly vaccined pediatric population. Infection 35:444–50
Brisson M, Edmunds WJ, Law B, Gay NJ, Walld R, Brownell M et al (2001) Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 127:305–14
Brison M, Edmunds WJ (2003) Epidemiology of varicella-zoster virus in England and Wales. J Med Virol 70(Suppl 1):S9–14
Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R (2007) Severe complications of chickenpox in hospitalized children in the UK and Ireland. Arch Dis Child 92:1062–1066
Carapetis JR, Russell DM, Curtis N (2004) The burden and cost of hospitalized varicella and zoster in Australian children. Vaccine 23:755–761
Davis MM (2006) Successes and remaining challenges after 10 years of varicella vaccination in the USA. Expert Rev Vaccines 5:295–302
Davis MM, Patel MS, Gebremariam A (2004) Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 114:786–792
Díez Domingo J, Ridao M, Latour J, Ballester A, Morant A (1999) A cost benefit analysis of routine varicella vaccination in Spain. Vaccine 17:1306–1311
Dubos F, Grandbastien B, Hue V, Hospital Network for Evaluating Management of Common Childhood Diseases, Martinot A (2007) Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect 135:131–138
Gil A, Oyagüez I, Carrasco P, González A (2001) Epidemiology of primary varicella hospitalizations in Spain. Vaccine 20:295–298
Gil A, San-Martín M, Carrasco P, González A (2004) Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine 22:3947–3951
Grimprel E, Levy C, de La Rocque F, Cohen R, Soubeyrand B, Caulin E et al (2007) Paediatric varicella hospitalisations in France: a nationwide survey. Clin Microbiol Infect 13:546–549
Grote V, von Kries R, Springer W, Hammersen G, Kreth HW, Liese J (2008) Varicella-related deaths in children and adolescents—Germany 2003–2004. Acta Paediatr 97:187–192
Heininger U, Seward JF (2006) Varicella. Lancet 368:1365–1376
Jaeggi A, Zurbruegg RP, Aebi C (1998) Complications of varicella in a defined central European population. Arch Dis Child 79:472–477
Kanra G, Tezcan S, Badur S (2002) Varicella seroprevalence in a random sample of the Turkish population. Vaccine 20:1425–1428
Koturoglu G, Kurugöl Z, Cetin N, Hizarcioglu M, Vardar F, Helvaci M et al (2005) Complications of varicella in healthy children in Izmir, Turkey. Pediatr Int 47:296–299
Koturoglu G, Kurugol Z, Turkoglu E (2011) Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults. Paediatr Perinat Epidemiol 25:388–393
Kurugol Z, Halicioglu O, Koc F, Koturoglu G, Aksit S (2011) Varicella rates among unvaccinated and one-dose vaccinated healthy children in Izmir, Turkey. Int J Infect Dis 15:e475–480
Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, v Kries R, ESPID Varicella Study Group (2008) The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J 27:119–124
Lin F, Hadler JL (2000) Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis 181:1897–1905
Lopez AS, Zhang J, Brown C, Bialek S (2011) Varicella-related hospitalizations in the United States, 2000–2006: the 1-dose varicella vaccination era. Pediatrics 127:238–245
Marin M, Güris D, Chaves SS, Schmid S, Seward JF (2007) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56(RR-4):1–40
Marchetto S, de Benedictis FM, de Martino M, Versace A, Chiappini E, Bertaine C et al (2007) Epidemiology of hospital admissions for chickenpox in children: an Italian multicenter study in the pre-vaccine era. Acta Paediatr 96:1490–1493
Nguyen HQ, Jumaan AO, Seward JF (2005) Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 352:450–458
Ozdemir H, Candir MO, Karbuz A, Belet N, Tapisiz A, Ciftci E, Ince E (2011) Chickenpox complications, incidence and financial burden in previously healthy children and those with an underlying disease in Ankara in the pre-vaccination period. Turk J Pediatr (in press)
Quian J, Rüttimann R, Romero C et al (2008) Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997–2005. Arch Dis Child 93:845–50
Rivest P, Bédard L, Valiquette L, Mills E, Lebel MH, Lavoie G et al (2001) Severe complications associated with varicella: Province of Quebec, April 1994 to March 1996. Can J Infect Dis 12:21–26
Shah SS, Wood SM, Luan X, Ratner AJ (2010) Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatr Infect Dis J 29:199–204
Sheffer R, Segal D, Rahamani S et al (2005) Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J 24:434–437
Theodoridou M, Laina I, Hadjichristodoulou C, Syriopoulou V (2006) Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction. Eur J Pediatr 165:273–274
Tseng HW, Liu CC, Wang SM, Yang YJ, Huang YS (2000) Complications of varicella in children: emphasis on skin and central nervous system disorders. J Microbiol Immunol Infect 33:248–252
Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ (2001) Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 108:E79
http://www.ecdc.europa.eu/en/publications/Publications/varicella_report_2000_2007_euvacnet.pdf
Acknowledgement
VARICOMP study results partly present as poster presentation in 27th Annual Meeting of European Society for Pediatric Infectious Disease, 6–11 June 2011, The Hague, Netherlands and partly present as an oral presentation in National Pediatric Infectious Disease Congress at 27–30 April, Antalya, Turkey.
Conflict of interest
Authors declare that they have no conflict of interest during the design, data collecting, analysis, and writing of manuscript.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Dinleyici, E.C., Kurugol, Z., Turel, O. et al. The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study). Eur J Pediatr 171, 817–825 (2012). https://doi.org/10.1007/s00431-011-1650-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-011-1650-z